Federal Register / Vol. 62, No. 33 / Wednesday, February 19, 1997 / Notices 7459

Dated: February 14, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–4229 Filed 2–14–97; 3:45 pm]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Delegations of Authority; Public Law

80–566, 62 Stat. 281, 40 U.S.C. 486(d)

and 40 U.S.C. 318a and 318b

Notice is hereby given that pursuant

to the authority granted to me by the

Acting Administrator of General

Services, signed on December 9, 1996, I

hereby delegate to you the following

authority.

1. Delegation: In accordance with

section 205 (d) and (e) of the Federal

Property and Administrative Service

Act of 1949, as amended, the

Administrator of General Services

hereby delegates and authorizes

successive redelegation of the authority

identified herein.

2. Authorities Delegated: Authorities

relating to the protection of Federal

property vested in the Administrator of

General Services by the Act of June 1,

1948, Public Law 80–566, 62 Stat. 281,

40 U.S.C. 486 (d), 40 USC 318a and

318b and the Federal Property and

Administrative Services Act of 1949, as

amended, 63 Stat. 377 are hereby

delegated to the Director, National

Institutes of Health (NIH) for the

protection of the property and persons

at NIH, National Cancer Institute’s (NCI)

facilities in Frederick Cancer Research

and Development Center (‘‘NCI parcel’’)

located in Frederick, MD.

3. Responsibilities and Limitations:

A. The NIH Director or designated

officials shall take steps to issue

regulations and to authorize successive

redelegations of authority to protect

persons and property identified in this

delegation. This may be accomplished

through the establishment of rules and

regulations governing conduct on the

affected property and execution of

agreements with other Federal, State, or

Local authorities.

B. This delegated authority is limited

to the properties identified in paragraph

2.

4. Disputes: Except as otherwise

provided in this delegation, any dispute

concerning a matter of act arising under

this delegation which is not disposed of

by mutual agreement shall be decided

by the Administrator of General

Services. The decision of the

Administrator on such matters shall be

final.

5. Termination and Modifications:

Any of all authority delegated may be

terminated by the Administrator of

General Services or the Attorney

General upon 120 days notice, if it is

determined that such action is in the

best interest of the Government.

6. Evaluation: Effectiveness of the

delegation of protection activities will

be evaluated on a continuing basis. This

evaluation may include random on-site

inspections and by meeting with HHS

officials. HHS will be given at least 30

days to submit comments for

incorporation in the final evaluation

report. HHS is encouraged to conduct

periodic assessments of its protection

program and provide an information

copy to the General Services

Administration.

7. Termination: Any or all authority

delegated may be terminated by the

Administrator of General Services or the

Secretary of HHS upon 120 days notice

if determined that such action is in the

best interest of the Government.

8. Term of Delegations: The

delegation is effective immediately.

Dated: January 28, 1997.

Donna E. Shalala,

Secretery of the Department of Health and

Human Services.

[FR Doc. 97–4037 Filed 2–18–97; 8:45 am]

BILLING CODE 4140–01–M

Office of the Secretary

Delegation of Authority; Patents and

Inventions

Notice is hereby given that I have

delegated to Heads of the Public Health

Service Operating Divisions all

authorities to administer and make

decisions regarding the invention and

patent program of their respective

Operating Divisions and the authority to

make determinations of rights in

inventions and patents in which the

Department has an interest, except as

specified below.

Restrictions

1. The Secretary retains authority to

submit reports to Congress.

2. This delegation excludes those

authorities under the Stevenson-Wydler

Technology Innovation Act of 1980, as

amended by the Federal Technology

Transfer Act of 1986 and the National

Technology Transfer and Advancement

Act of 1995, which are governed by a

separate delegation.

Redelegation

All authorities other than the

authority under 35 U.S.C. 203 (Marchin Rights) may be redelegated.

Prior Delegations

The prior delegations of authority, to

the PHS Agency Heads (retitled Heads

of Operating Divisions), derived from

authority given to the Assistant

Secretary for Health (ASH) in 45 CFR

Part 6. Those regulations were recently

rescinded because they were obsolete

(61 FR 54743 (October 22, 1996)). In

addition, the delegation of authority

from the ASH to the then-PHS Agency

Heads dated July 15, 1988, which was

amended by a memorandum dated July

24, 1991 from the ASH to the Director,

National Institutes of Health is hereby

superseded. Prior redelegations by the

PHS Agency Heads under that authority

shall remain in effect unless modified

by PHS Operating Division Heads.

Ratification

All actions taken by the Heads of PHS

Operating Divisions or their

subordinates from October 22, 1996 to

the effective date of this delegation that

would have been authorized under 45

CFR 6.2 and delegations thereunder are

hereby ratified.

Effective Date

Effective upon signature.

Dated: January 31, 1997.

Donna E. Shalala,

Secretary of the Department of Health and

Human Services.

[FR Doc. 97–4038 Filed 2–18–97; 8:45 am]

BILLING CODE 4150–04–M

Centers for Disease Control and

Prevention

[INFO–97–04]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for

opportunity for public comment on

proposed data collection projects, the

Centers for Disease Control and

Prevention (CDC) will publish periodic

summaries of proposed projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call the CDC Reports

Clearance Officer on (404) 639–7090.

Comments are invited on: (a) Whether

the proposed collection of information

is necessary for the proper performance
7460 Federal Register / Vol. 62, No. 33 / Wednesday, February 19, 1997 / Notices

of the functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques

for other forms of information

technology. Send comments to Wilma

Johnson, CDC Reports Clearance Officer,

1600 Clifton Road, MS–D24, Atlanta,

GA 30333. Written comments should be

received within 60 days of this notice.

Proposed Projects

1. The Tri-State Mining District: Lead

Exposure and Immunotoxic Effects

Study—New—The proposed study

evaluates associations between immune

system dysfunction/damage and

exposure to lead among children in the

Tri-State Mining District. This district

encompasses several contaminated areas

including three Superfund sites: The

Oronogo-Duenweg Mining Belt site in

Jasper County, Missouri; the Cherokee

County Site in Kansas; and the Tar

Creek, Ottawa County Site in Oklahoma.

The proposed study consists of two

repeated in-person interviews and

biological testing for blood lead and

immune function among participants of

the ongoing lead screening programs in

the Tri-State Mining district.

Approximately 50 children identified as

having blood lead <10 micrograms per

decilitre and 50 children with blood

lead levels <5 micrograms per decilitre

will constitute the study and

comparison groups respectively. Blood

specimens will be obtained to measure

lead, complete blood count, EP, ZPP,

antibody titers, and the CDC/ATSDR

recommended immune panel. A second

blood drawn a month later will examine

intra-personal immune tests stability

and will help evaluate the relationship

between immune results and recent

illness. Parents will be interviewed

using a children’s health questionnaire

that solicits information on

demographics, the medical history of

each child and the occurrences of recent

illness. Statistical analyses will compare

health outcome measures (symptoms,

illness, change in immune parameters)

to blood lead levels. Other than their

time, there will be no cost to the

respondents. The length of clearance

requested is 3 years.

Respondents Number of

respondents

Number of

reponses/

respondent

Average

burden/response

(in hrs)

Total burden

(in hrs.)

Child Health Questionnaire .............................................................................................. 100 2 0.5 100

Total ........................................................................................................................... .................... .................... .................... 100

Dated: February 12, 1997.

Wilma G. Johnson,

Acting Associate Director for Policy Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–4006 Filed 2–18–97; 8:45 am]

BILLING CODE 4163–18–P

[30DAY–30]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Office on (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

The following requests have been

submitted for review since the last

publication date on February 11, 1997.

Proposed Project

The Second Longitudinal Study of

Aging (LSOA II)—(0920–0219)—New—

The Second Longitudinal Study of

Aging is a second generation,

longitudinal survey of a nationally

representative sample of civilian, noninstitutionalized persons 70 years of age

and older. Participation is voluntary,

and individually identified data are

confidential. It will replicate portions of

the first Longitudinal Study of Aging

(LSOA), particularly the causes and

consequences of changes in functional

status. LSOA II is also designed to

monitor the impact of changes in

Medicare, Medicaid, and managed care

on the health status of the elderly and

their patterns of health care utilization.

Both LSOAs are joint projects of the

National Center for Health Statistics

(NCHS) and the National Institute on

Aging (NIA).

The Supplement on Aging (SOA), part

of the 1984 National Health Interview

Survey (NHIS), established a baseline on

7,527 persons who were then aged 70

and older. The first LSOA reinterviewed

them in 1986, 1988 and 1990. Data from

the SOA and LSOA have been widely

used for research and policy analysis

relevant to the older population.

Approximately 10,000 persons aged

70 and over were interviewed for the

1994 National Health Interview Survey’s

second Supplement on Aging (SOA II)

between October of 1994 and March of

1996. LSOA II will reinterview the SOA

II sample three times: In 1997, 1999, and

2001. As in the first LSOA, these

reinterviews will be conducted using

computer assisted telephone

interviewing (CATI). Beyond that, LSOA

II will use methodological and

conceptual developments of the past

decade.

LSOA II will contain modules on

scientifically important and policyrelevant domains, including: (1)

Assistance with activities of daily

living, (2) chronic conditions and

impairments, (3) family structure,

relationships, and living arrangements,

(4) health opinions and behaviors, (5)

use of health, personal care and social

services, (6) use of assistive devices and

technologies, (7) health insurance, (8)

housing and long-term care, (9) social

activity, (10) employment history, (11)

transportation, and (12) cognition. This

new data will result in publication of

new national health statistics on the

elderly and the release of public use

micro data files. The total annual

burden is 8,099.